Laboratory-confirmed SARS-CoV-2 reinfection in the population treated at social security.

Respir Med Case Rep

Instituto Mexicano del Seguro Social. Coordinación de Investigación en Salud. Av. Cuauhtémoc # 330, Bloque "B" 4° piso, Anexo a la Unidad de Congresos del Centro Médico Nacional Siglo XXI, Col. Doctores, Alcaldía Cuauhtémoc, CP. 06720, Ciudad de México, México.

Published: August 2021

The scientific community has questioned whether reinfection with SARS-CoV-2 is possible. Gradually, cases of reinfection have been documented. In Mexico, people with SARS-CoV-2 reinfection have not been officially identified. To allow a retrospective investigation of patients with PCR-confirmed SARS-CoV-2 and to identify how reinfected with this virus occurs in a population that requires medical attention. A retrospective search of the epidemiological surveillance system was performed to identify people who met the clinical criteria based on laboratory diagnosis of SARS-CoV-2 and temporality to identify cases of reinfection. Clinical information was collected from clinical records. Seven people with two separate COVID-19 events were identified in medical units in Quintana Roo, Mexico between April and December 2020. The overall median interval between the two events was 156 days (61-191 days). Six people were health workers, and one was a member of the general population. This is one of the first reports of reinfection in health personnel in Mexico, revealing that the frequency of reinfection is low among positive cases and that the interval between infection episodes was three months. There are several scenarios in the natural history of the disease that must be considered based on adequate anamnesis with a clinical-epidemiological approach to determine the correct diagnostic category.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351271PMC
http://dx.doi.org/10.1016/j.rmcr.2021.101493DOI Listing

Publication Analysis

Top Keywords

sars-cov-2 reinfection
8
cases reinfection
8
reinfection
7
laboratory-confirmed sars-cov-2
4
reinfection population
4
population treated
4
treated social
4
social security
4
security scientific
4
scientific community
4

Similar Publications

This letter highlights the crucial distinction between studying HLA alleles in unvaccinated individuals during the acute phase of primary SARS-CoV-2 infection versus any SARS-CoV-2 infection including re-infections, breakthrough infections, and primary infections in vaccinated individuals.

View Article and Find Full Text PDF

Background: In May 2022, after the suspension of the mobility restrictions due to the COVID-19 pandemic, the first outbreak of MPOX virus, transmitted from human to human, was detected outside of Africa, affecting mostly sexually active men who have sex with men. Our aim is to report the first outbreak of MPOX in Barcelona city in the period from 5/2022 to 5/2023 and the subsequent surge of cases in 8/2023.

Methods: We performed a descriptive study of all notified cases in city residents, obtained through epidemiological surveys.

View Article and Find Full Text PDF

The underlying mechanisms explaining the differential course of SARS-CoV-2 infection and the potential clinical consequences after COVID-19 resolution have not been fully elucidated. As a dysregulated mitochondrial activity could impair the immune response, we explored long-lasting changes in mitochondrial functionality, circulating cytokine levels, and metabolomic profiles of infected individuals after symptoms resolution, to evaluate whether a complete recovery could be achieved. Results of this pilot study evidenced that different parameters of aerobic respiration in lymphocytes of individuals recuperated from a severe course lagged behind those shown upon mild COVID-19 recovery, in basal conditions and after simulated reinfection, and they also showed altered glycolytic capacity.

View Article and Find Full Text PDF

This study introduces a five-compartment model to account for the impacts of vaccination-induced recovery and nonlinear treatment rates in settings with limited hospital capacity. To reflect real-world scenarios, the model incorporates multiple reinfections in both vaccinated and recovered groups. It reveals a range of dynamics, including a disease-free equilibrium and up to six endemic equilibria.

View Article and Find Full Text PDF

Background/objectives: The emergence of the Omicron variant has complicated COVID-19 control and prompted vaccine updates. Recent studies have shown that a fourth dose significantly protects against infection and severe disease, though long-term immunity data remain limited. This study aimed to assess Anti-S-RBD antibodies and interferon-γ levels in healthcare workers 12 months after receiving bivalent Original/Omicron BA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!